{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:57:51Z","timestamp":1759481871919},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1093\/ndt\/gfl774","type":"journal-article","created":{"date-parts":[[2007,2,18]],"date-time":"2007-02-18T01:05:56Z","timestamp":1171760756000},"page":"1428-1436","source":"Crossref","is-referenced-by-count":35,"title":["The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective"],"prefix":"10.1093","volume":"22","author":[{"given":"Ruth","family":"Garside","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Mealing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,2,17]]},"reference":[{"key":"key\n\t\t\t\t20170518083042_B1","article-title":"Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral of Adults","author":"Joint Specialty Committee on Renal Disease","year":"2005"},{"key":"key\n\t\t\t\t20170518083042_B2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/jarr.2002.34842","article-title":"Secondary hyperparathyroidism and its therapy as a cardiovascular risk factor among end-stage renal disease patients","volume":"9","author":"Coladonato","year":"2002","journal-title":"Adv Renal Replacet Th"},{"key":"key\n\t\t\t\t20170518083042_B3","first-page":"306","article-title":"Detection and clinical management of cardiovascular calcification in ESRD: a review","volume":"33","author":"Ehrlich","year":"2004","journal-title":"Dialysis Transplant"},{"key":"key\n\t\t\t\t20170518083042_B4","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.clinthera.2004.12.011","article-title":"Secondary hyperparathyroidism: review of the disease and its treatment","volume":"26","author":"de Francisco","year":"2004","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20170518083042_B5","volume-title":"UK Renal Registry 7th Annual Report.","author":"Ansell","year":"2004"},{"key":"key\n\t\t\t\t20170518083042_B6","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0085-2538(15)51229-5","article-title":"Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease","volume":"68","author":"Quarles","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518083042_B7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCI on cardiovascular disease, fracture, and health related quality of life in secondary hyperparathryoidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518083042_B8","doi-asserted-by":"crossref","DOI":"10.3310\/hta11180","article-title":"The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end stage renal disease patients on dialysis: a systematic review and economic evaluation","author":"Garside","year":"2007","journal-title":"Health Technology Assessment"},{"key":"key\n\t\t\t\t20170518083042_B9","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"New Engl J Mede"},{"key":"key\n\t\t\t\t20170518083042_B10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Medl Decis Making"},{"key":"key\n\t\t\t\t20170518083042_B11","article-title":"Guide to the Methods of Technology Appraisal 17","author":"National Institute for Clinical Excellence","year":"2004"},{"key":"key\n\t\t\t\t20170518083042_B12","volume-title":"UK Renal Registry - the Sixth Annual Report.","author":"Ansell","year":"2003"},{"key":"key\n\t\t\t\t20170518083042_B13","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality and morbidity in maintainance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20170518083042_B14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0272-6386(03)00359-7","article-title":"Heart failure as a cause for hospitalization in chronic dialysis patients","volume":"41","author":"Trespalacios","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20170518083042_B15","article-title":"Association of elevated parathyroid hormone (PTH) and calcium with risk of hip, vertebral or pelvic fracture in hemodialysis patients","author":"Kim","year":"2004"},{"key":"key\n\t\t\t\t20170518083042_B16","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta9220","article-title":"A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of osteoporosis","volume":"9","author":"Stevenson","year":"2005","journal-title":"Health Technology Assessment"},{"key":"key\n\t\t\t\t20170518083042_B17","article-title":"Guide to the Methods of Technology Appraisal","year":"2004"},{"key":"key\n\t\t\t\t20170518083042_B18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00019053-199915050-00004","article-title":"The revised Canadian guidelines for the economic evaluation of pharmaceuticals","volume":"15","author":"Glennie","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"key\n\t\t\t\t20170518083042_B19","article-title":"Reference Costs 2004","year":"2005"},{"key":"key\n\t\t\t\t20170518083042_B20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hec.635","article-title":"Representing uncertainty: the role of cost-effectiveness acceptability curves","volume":"10","author":"Fenwick","year":"2001","journal-title":"Health Econ"},{"key":"key\n\t\t\t\t20170518083042_B21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.329.7459.224","article-title":"National Institute for Clinical Excellence and its value judgments","volume":"329","author":"Rawlins","year":"2004","journal-title":"Brit Med J"},{"key":"key\n\t\t\t\t20170518083042_B22","first-page":"68","article-title":"Costing in economic evaluations","volume-title":"Economic evaluation in health care: merging theory with practice.","author":"Brouwer","year":"2005"},{"key":"key\n\t\t\t\t20170518083042_B23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oso\/9780195108248.003.0002","article-title":"Theoretical foundations of cost-effectiveness analysis","volume-title":"Cost-effectiveness in health and medicine.","author":"Garber","year":"1996"},{"key":"key\n\t\t\t\t20170518083042_B24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/01.ASN.0000113243.24155.2F","article-title":"Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes","volume":"15","author":"Stevens","year":"2004","journal-title":"J Am Sof Nephrol"},{"key":"key\n\t\t\t\t20170518083042_B25","first-page":"155","article-title":"Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation","volume":"9","author":"Loghman-Adham","year":"2003","journal-title":"Amn J Manag Ce"},{"key":"key\n\t\t\t\t20170518083042_B26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","author":"Mittalhenkle","year":"2004","journal-title":"Am J Kidney Dise"},{"key":"key\n\t\t\t\t20170518083042_B27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"New Engl J Mede"},{"key":"key\n\t\t\t\t20170518083042_B28","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA-J Am Med Assoc"},{"key":"key\n\t\t\t\t20170518083042_B29","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","article-title":"Epidemiology of Fractures in England and Wales","volume":"29","author":"van Staa","year":"2001","journal-title":"Bone"},{"key":"key\n\t\t\t\t20170518083042_B30","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1046\/j.1523-1755.63.s85.23.x","article-title":"Parathyroidecomty: whom and when?","volume":"63","author":"Jofre","year":"2003","journal-title":"Kidney Intt"},{"key":"key\n\t\t\t\t20170518083042_B31","first-page":"641","article-title":"Long term results of subtotal parathyroidectomy in patients with end-stage renal disease","volume":"60","author":"Kim","year":"1994","journal-title":"Am J Sury"},{"key":"key\n\t\t\t\t20170518083042_B32","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170518083042_B33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-8510(98)00017-7","article-title":"Economic evaluation of end stage renal disease treatment","volume":"44","author":"de Wit","year":"1998","journal-title":"Health Policy"},{"key":"key\n\t\t\t\t20170518083042_B34","article-title":"Preference Weights 1998\u20132001. The Cost-Effectiveness Analysis Registry","author":"Harvard Centre for Risk Analysis","year":"2006"},{"key":"key\n\t\t\t\t20170518083042_B35","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.1995.03520390045031","article-title":"Variation in patient utilities for outcomes of the management of chronic stable angina: implications for clinical practice guidelines. Ischemic heart disease team","volume":"273","author":"Nease","year":"1995","journal-title":"JAMA-J Am Medl Assoc"},{"key":"key\n\t\t\t\t20170518083042_B36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modelling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20170518083042_B37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s001980200107","article-title":"Committee of scientific advisors international osteoporosis foundation: a systematic review of health state utility values for osteoporosis-related conditions","volume":"13","author":"Brazier","year":"2002","journal-title":"Osteoporosis Intl"},{"key":"key\n\t\t\t\t20170518083042_B38","article-title":"British National Formulary No. 50 (September 2005) 1644","author":"BMA & RPSGB","year":"2005"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/22\/5\/1428\/17171315\/gfl774.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,11]],"date-time":"2024-02-11T00:58:22Z","timestamp":1707613102000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfl774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,17]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,2,17]]},"published-print":{"date-parts":[[2007,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfl774","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2,17]]}}}